HIMSS buys CapSite for comparative pricing info

Editorial Staff | | Health Exec | Policy & Regulations
The Healthcare Information and Management Systems Society (HIMSS) acquired CapSite, a healthcare technology and consulting organization based in Burlington, Vt., effective Oct. 1.

The CapSite Database provides pricing data on vendor products and services to include proposals (with actual documents) and final negotiated contract pricing. The current database offers more than 5,000 contracts across 160 categories representing 1,600 vendors with analysis of interest to chief information officers and primary buyers of information systems, products and services, as well as supply chain and acquisition executives.

The investment in CapSite follows the society's strategy for HIMSS Analytics to provide market intelligence on the hardware, software and services selected by CIOs and other users of IT, H. Stephen Lieber, HIMSS president and CEO, said in a statement. “We will maintain the CapSite office in Burlington, Vt., with CapSite employees joining the HIMSS roster as part of the HIMSS Analytics team." 

The current HIMSS Analytics data do not include comparative pricing information that CIOs and other buyers of health IT data often need, and the CapSite database offers that pricing information, said HIMSS.  

In addition, HIMSS Analytics will now offer voice-of-customer consulting services through research, information often sought out by both healthcare providers and vendors.

Editorial Staff

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”